ORYZON announces Notice of Allowance for U.S. patent application covering iadademstat com... 31/08/2026 Healthcare Drug discovery Innovative drugs Iadademstat is under clinical development in acute myeloid leukemia (AML), including in combination with gilteritinib in... Partners - Oryzon Genomics
Neural Omega to present its full molecular mimicry pipeline at BioSpain 2026 31/08/2026 Healthcare Access to innovation Drug discovery From clinical data to drug discovery: Madrid-based biotech Neural Omega will make its international debut at BioSpain... Partners - NEURAL OMEGA
Celtarys Research expands into Targeted Protein Degradation with new tools for PROTAC and ... 28/08/2026 Healthcare Drug discovery Innovative drugs Celtarys Research has expanded its drug discovery portfolio into Targeted Protein Degradation (TPD), launching new... Partners - Celtarys Research
Biobide's DNT assay validated by NIH and US-EPA 01/07/2026 Healthcare Drug discovery International A study led by NIEHS/NIH, with participation from Biobide, the US-EPA, the University of Konstanz, and the IUF-Leibniz... Partners - Biotechnology Assets
ORYZON Presents Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia ... 11/06/2026 Healthcare Drug discovery Innovative drugs In first line AML (ALICE-2 trial), iadademstat with azacitidine and venetoclax showed high levels of clinical activity... Partners - Oryzon Genomics
Choosing the Right Crystal: Solid Form Optimization for Pharmaceutical Development Online Del 10/06/2026 to 10/06/2026 Healthcare Drug discovery International
Festival of Biologics Basel Switzerland Del 13/10/2026 to 15/10/2026 Healthcare Biosimilars Drug discovery Advanced therapies
BIOTECHX USA Boston United States Del 29/09/2026 to 30/09/2026 Healthcare Drug discovery Personalized medicine International
ORYZON initiates patient enrollment in IDEAL Phase II trial of iadademstat in essential t... 02/06/2026 Healthcare Drug discovery Innovative drugs Oryzon Genomics, a clinical-stage biopharmaceutical company and a global leader in epigenetics, today announced that the... Partners - Oryzon Genomics
BioClonal seeks strategic partnerships to advance its Alzheimer’s antibody program and ant... 02/06/2026 Healthcare Access to innovation Drug discovery Innovative drugs Spanish biotechnology company BioClonal is advancing a proprietary monoclonal antibody program targeting a novel... Partners - BIOCLONAL
